Approximately 350 million people worldwide suffer from diabetes mellitus (DM) and this
number increases yearly. Since the discovery and clinical application of insulin in 1921,
subcutaneous injections have been the ...
Over the past couple of years there has been rapid progress in the development and design of
safe and effective delivery systems for the administration of protein and peptide drugs. The
effective delivery of these type ...
Advances in biotechnology and recombinant technologies have lead to the
production of several classes of new drugs such as peptide and protein drugs.
These compounds are mostly indicated for chronic use but their ...